Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancer.
Saved in:
| Title: | Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancer. |
|---|---|
| Authors: | Abbas MN; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, South Australia, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, Australia., Klevansky M; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, South Australia, Australia., Koczwara B; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, South Australia, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, Australia., Roy AC; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, South Australia, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, Australia., Sukumaran S; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, South Australia, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, Australia., Vatandoust S; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, South Australia, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, Australia., Karapetis CS; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, South Australia, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, Australia. |
| Source: | Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2022 Mar; Vol. 5 (3), pp. e1487. Date of Electronic Publication: 2021 Jun 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
